Merck (MRK) Receivables - Other (2009 - 2023)

Merck has disclosed Receivables - Other across 12 years of filings, most recently posting $473.0 million for Q1 2023.

• In Q1 2023, Receivables - Other fell 34.21% year-over-year to $473.0 million; the TTM figure through Mar 2023 stood at $473.0 million (down 34.21% YoY), while the FY2022 annual figure was $511.0 million, down 46.99% from the prior year.
• Receivables - Other slipped to $473.0 million in Q1 2023, from $511.0 million in the prior quarter.
• Over the last five years, Receivables - Other for MRK reached as high as $1.6 billion in Q2 2021 and fell as low as $473.0 million in Q1 2023.
• The 3-year median for Receivables - Other is $684.0 million (2022), against an average of $860.4 million.
• Annual changes were most pronounced in 2022 — Receivables - Other sank 59.5% — and 2023, when it slumped 34.21%.
• A 3-year view of Receivables - Other shows it stood at $964.0 million in 2021, then tumbled by 46.99% to $511.0 million in 2022, then dropped by 7.44% to $473.0 million in 2023.
• According to Business Quant data, Receivables - Other over the past three periods registered $473.0 million, $511.0 million, and $567.0 million for Q1 2023, Q4 2022, and Q3 2022 respectively.